doctors and patients deplore the lack of innovative treatments in France
In France, only one drug is available but its effects remain modest. Yet there are potentially effective new treatments that take too long to reach patients. With Charcot’s disease, life expectancy hardly exceeds a few years. New treatments could offer invaluable months of life. But their authorization is slow in Europe, to the regret of … Read more